Pathogenesis and Management of Urinary Tract Infections

Urinary tract infections (UTIs) arise when uropathogens breach the urothelial barrier and establish colonisation within the bladder, ureters or kidneys. The principal culprit, uropathogenic Escherichia coli (UPEC), employs a suite of adhesins, toxins and iron‐acquisition systems to adhere to epithelial surfaces, resist host defences and form intracellular communities that seed recurrent disease. Host responses range from rapid urothelial exfoliation and antimicrobial peptide secretion to recruitment of neutrophils and macrophages, yet these innate reactions can sometimes predispose to chronic inflammation and relapse. Standard management relies on targeted antibiotic regimens guided by susceptibility testing, but the mounting threat of antimicrobial resistance has driven interest in non-antibiotic strategies. These include vaccines against extraintestinal pathogenic strains, small-molecule inhibitors of bacterial adhesion and modulation of the microbiota to restore colonisation resistance. Preventive approaches such as behavioural modification, prophylactic dosing and antimicrobial stewardship play a vital role in reducing recurrence and preserving antibiotic efficacy. Emerging insights into host–pathogen interactions and microbial physiology are reshaping our understanding of UTI pathogenesis and opening new avenues for durable interventions.

Research from Nature Portfolio

Recent studies have uncovered that prior UPEC infection imprints durable changes on bladder epithelial stem cells via epigenetic remodelling, enhancing innate responsiveness upon re-exposure but also promoting inflammatory sequelae associated with recurrent cystitis. This work reveals how chromatin accessibility and histone modifications in urothelial cells can encode a form of ‘trained immunity’, influencing both bacterial clearance and tissue damage in subsequent infections. Foundational structural analyses have elucidated the catch-bond mechanism of the FimH adhesin at the tip of type I pili, showing that mechanical force induces a conformational shift that strengthens bacterial attachment under urinary shear stress. This atomic-level model of force-enhanced binding provides a blueprint for designing high-affinity anti-adhesive compounds that block colonisation and biofilm formation.

Pathogenesis and Management of Urinary Tract Infections publication trend

The graph below shows the total number of articles in pathogenesis and management of urinary tract infections across all publications each year (not limited to Nature Index journals).

Technical terms

Uropathogenic Escherichia coli (UPEC): Strains of E. coli adapted to colonise the urinary tract and cause infection.

Adhesin: A bacterial surface protein that mediates attachment to host cells, exemplified by FimH on type I pili.

Catch-bond: A receptor–ligand interaction that strengthens under tensile force, enhancing bacterial adhesion in flowing urine.

Epigenetic imprinting: Stable chemical modifications of DNA or histones that alter gene expression without changing the underlying sequence.

Trained immunity: A form of innate immune memory in which prior exposure enhances subsequent responses to the same or different pathogens.

Antimicrobial stewardship: Coordinated efforts to optimise the use of antibiotics, minimise resistance and improve patient outcomes.

References

1. Uropathogenic Escherichia coli infection-induced epithelial trained immunity impacts urinary tract disease outcome. Nature Microbiology (2023).
2. Vaccines against extraintestinal pathogenic Escherichia coli (ExPEC): progress and challenges. Gut Microbes (2024).
3. UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies. Frontiers in Microbiology (2017).
4. Catch-bond mechanism of the bacterial adhesin FimH. Nature Communications (2016).